Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05014035 · ClinicalTrials.gov registry record · NA

Feasibility of a Hybrid Delivery of Home-based Cluster Set Resistance Training in Lung Cancer

A NA study of Non-Small Cell Lung Cancer and Resistance Exercise, sponsored by University of South Carolina.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT05014035: Completed NA study of Non-Small Cell Lung Cancer and Resistance Exercise, sponsored by University of South Carolina.

NCT05014035 is a NA study of Non-Small Cell Lung Cancer and Resistance Exercise that has completed, run by University of South Carolina. The registered enrollment target is 14 participants, below the 652-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05014035, a NA study of Non-Small Cell Lung Cancer and Resistance Exercise, has completed, sponsored by University of South Carolina.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

Symptom burden remains a critical concern for individuals with non-small cell lung cancer (NSCLC) following the completion of treatment. Of those, symptom clusters such as dyspnea (shortness of breath) and fatigue, contribute to physical decline, reductions in quality of life, and a higher risk of comorbidities and mortality. It has been proposed that dyspnea is a primary limiter of exercise capacity in individuals with lung cancer, resulting in exercise avoidance and an accelerated physical decline. As such, specifically designing resistance exercise programs with cluster sets, to mitigate feelings of dyspnea and fatigue may result in improved exercise tolerance, resulting in the maintenance of physical function and quality of life. The purpose of this project is to investigate the feasibility and preliminary efficacy of a hybrid-delivery of home-based cluster-set resistance exercise in individuals with NSCLC. Methods: Individuals with NSCLC (n=15), within 12-months of completion of treatment will be recruited to participate in this single arm feasibility trial. Participants will complete 8-weeks of home-based resistance training (RT) designed to target dyspnea and fatigue. The hybrid-delivery of the program will include supervised sessions in the participants home, and virtual supervision via video conferencing. The primary outcome of feasibility will be measured via recruitment rates, retention, acceptability and intervention fidelity. Exploratory outcomes (dyspnea, fatigue, quality of life, physical function and body composition) will be assessed pre- and post- intervention.

Primary Outcome

The recruitment goal of n=15 is reached

Interventions

  • BEHAVIORAL Resistance Exercise

Study Locations (1)

South Carolina

  • University of South Carolina - Columbia

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2022-01-01
Est. Completion 2022-09-22
Phase NA
University of South Carolina

157 total trials

What the finished NCT05014035 record still lists

NCT05014035 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 652-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Resistance Exercise is the first listed.

NCT05014035 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT05014035 about?

NCT05014035 is a clinical study titled "Feasibility of a Hybrid Delivery of Home-based Cluster Set Resistance Training in Lung Cancer". Symptom burden remains a critical concern for individuals with non-small cell lung cancer (NSCLC) following the completion of treatment. Of those, symptom clusters such as dyspnea (shortness of breath) and fatigue, contribute to physical decline, reductions in quality of life, and a higher risk of c...

What is the current status of trial NCT05014035?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-01-01. Estimated completion is 2022-09-22.

What conditions does trial NCT05014035 study?

This clinical trial studies the following conditions: Non-Small Cell Lung Cancer, Resistance Exercise.

What interventions are being tested in trial NCT05014035?

The interventions under investigation include: Resistance Exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT05014035?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05014035 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Non-Small Cell Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05014035's enrollment target sits among peer trials

14 432nd of 454 higher than 22 of 454 other Non-Small Cell Lung Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Non-Small Cell Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02523092 · 14 participants · Phase 4

    Use of CXCL9 as a Biomarker of Acthar Efficacy

  • NCT04263285 · 14 participants · NA

    Treatment of Depression Post-SCI

  • NCT04743271 · 14 participants · NA

    Food and Circadian Timing

  • NCT05065671 · 14 participants · Phase 1

    Microbiome Derived Metabolism and Pharmacokinetics

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT05014035, the US trial registry maintained by the National Library of Medicine. NCT05014035 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.